This POC Biosensor Detects Oral Cancer

The point-of-care biosensor gives rapid results and is ideal for low resource and remote regions where conventional tests aren’t available.

Screenshot 2023 01 06 At 8 53 29 Am
University of Florida

Early detection of oral cancer is key for survival. It has been reported that localized oral cancers 2 cm or less in size can be treated easily with a five-year survival rate of over 90%. However, early detection requires accessibility to accurate diagnostics. According to a recent Medgadget article, University of Florida scientists have developed a point-of-care biosensor for the rapid detection of oral cancer. The testing device employs strips similar to those used in blood glucose tests to identify CIP2A, a protein biomarker that indicates the presence of oral cancer. 

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026